Evidence map›Paper›PMID 38969303›Full record

ArticleJournal of thrombosis and haemostasis : JTH2024

Prospective, international, multisite comparison of platelet isolation techniques for genome-wide transcriptomics: communication from the SSC of the ISTH.

Meenakshi Banerjee, Jesse W Rowley, Chris J Stubben, Neal D Tolley, Kathleen Freson, Benjamin Nelson, Béla Nagy, Zsolt Fejes, Antoinette M Blair, Ernest Turro and 14 more

Abstract readComparative StudyMulticenter Study
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Meenakshi BanerjeeUniversity of Utah Molecular Medicine Program, Eccles Institute of Human Genetics, Salt Lake City, Utah, USA.
Jesse W RowleyUniversity of Utah Molecular Medicine Program, Eccles Institute of Human Genetics, Salt Lake City, Utah, USA; Department of Internal Medicine, University of Utah Health, Salt Lake City, Utah, USA.
Chris J StubbenBioinformatics Shared Resource, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.
Neal D TolleyUniversity of Utah Molecular Medicine Program, Eccles Institute of Human Genetics, Salt Lake City, Utah, USA.
Kathleen FresonDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, Katholeike Universiteit (KU) Leuven, Leuven, Belgium.
Benjamin NelsonUniversity of Utah Molecular Medicine Program, Eccles Institute of Human Genetics, Salt Lake City, Utah, USA.
Béla NagyDepartment of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Zsolt FejesDepartment of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Antoinette M BlairUniversity of Utah Molecular Medicine Program, Eccles Institute of Human Genetics, Salt Lake City, Utah, USA.
Ernest TurroDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Paolo GreseleDepartment of Medicine and Surgery, University of Perugia, Perugia, Italy.
Giulia Ciarrocca TarantaDepartment of Medicine and Surgery, University of Perugia, Perugia, Italy.
Loredana BuryDepartment of Medicine and Surgery, University of Perugia, Perugia, Italy.
Emanuela FalcinelliDepartment of Medicine and Surgery, University of Perugia, Perugia, Italy.
Marie LordkipanidzéResearch Center, Montreal Heart Institute, Montreal, Quebec, Canada; Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
Marie-Christine AlessiCardiovascular and Nutrition Centre (C2VN), Aix Marseille University, Institut National de la Sante et de la Recherche Medicale (INSERM), National Research Institute for Agriculture, Food and Environment (INRAE), Marseille, France.
Andrew D JohnsonPopulation Sciences Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, Framingham, Massachusetts, USA; The Framingham Heart Study, Framingham, Massachusetts, USA.
Tamam BakchoulDepartment of Transfusion Medicine, Medical Faculty of Tubingen, University of Tubingen, Tubingen, Germany.
Sofia RamstromCardiovascular Research Centre, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Mattia FrontiniDepartment of Clinical and Biomedical Sciences, University of Exeter Medical School, Faculty of Health and Life Sciences, Exeter, United Kingdom.
Marina CameraUnit of Cell and Molecular Biology in Cardiovascular Diseases, Centro Cardiologico Monzino, Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy; Department of Pharmaceutical Sciences, Università Degli Studi Di Milano, Milan, Italy.
Marta BrambillaUnit of Cell and Molecular Biology in Cardiovascular Diseases, Centro Cardiologico Monzino, Instituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Robert A CampbellUniversity of Utah Molecular Medicine Program, Eccles Institute of Human Genetics, Salt Lake City, Utah, USA; Department of Internal Medicine, University of Utah Health, Salt Lake City, Utah, USA.
Matthew T RondinaUniversity of Utah Molecular Medicine Program, Eccles Institute of Human Genetics, Salt Lake City, Utah, USA; Department of Internal Medicine, University of Utah Health, Salt Lake City, Utah, USA; George E. Wahlen Veterans Affairs Medical Center & Geriatric Research Education and Clinical Center (GRECC), Salt Lake City, Utah, USA. Electronic address: matthew.rondina@hsc.utah.edu.

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Integrative analysis of whole genomes and transcriptomes from multiple cell types in rare disease patientsR01HL161365 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ernest Turro · 2023 to 2026
$2.6M
Evaluation of genetic variants affecting platelet function with CRISPR HDR in human megakaryocytesR01HL166805 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI JESSE ROWLEY · 2023 to 2026
$2.1M
Translational Control of Megakaryocyte and Platelet Function in SepsisR01HL142804 · NHLBI · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2018 to 2021
$1.9M
Platelet-Leukocyte Interactions in SepsisK24HL155856 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2021 to 2025
$606k
Platelet Reprogramming During InflammationI01CX001696 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI Matthew Thomas Rondina · 2018 to 2026
–
American Heart Association-American Stroke Association 902619British Heart Foundation FS/18/53/33863CSRD VA I01 CX001696NCI NIH HHS P30 CA042014NHLBI NIH HHS K24 HL155856NHLBI NIH HHS R01 HL142804NHLBI NIH HHS R01 HL161365NHLBI NIH HHS R01 HL166805
6 · The paper itself

Abstract

Genome-wide platelet transcriptomics is increasingly used to uncover new aspects of platelet biology and as a diagnostic and prognostic tool. Nevertheless, platelet isolation methods for transcriptomic studies are not standardized, introducing challenges for cross-study comparisons, data integration, and replication. In this prospective multicenter study, called "Standardizing Platelet Transcriptomics for Discovery, Diagnostics, and Therapeutics in the Thrombosis and Hemostasis Community (STRIDE)" by the International Society on Thrombosis and Haemostasis Scientific and Standardization Committees, we assessed how 3 of the most commonly used platelet isolation protocols influence metrics from next-generation bulk RNA sequencing and functional assays. Compared with washing alone, more stringent removal of leukocytes by anti-CD45 beads or PALL filters resulted in a sufficient quantity of RNA for next-generation sequencing and similar quality of RNA sequencing metrics. Importantly, stringent removal of leukocytes resulted in the lower relative expression of known leukocyte-specific genes and the higher relative expression of known platelet-specific genes. The results were consistent across enrolling sites, suggesting that the techniques are transferrable and reproducible. Moreover, all 3 isolation techniques did not influence basal platelet reactivity, but agonist-induced integrin αIIbβ

Indexed as

Blood PlateletsGene Expression ProfilingTranscriptomeCell SeparationHigh-Throughput Nucleotide SequencingHumansLeukocyte Common AntigensPlatelet Glycoprotein GPIIb-IIIa ComplexProspective StudiesReproducibility of ResultsLeukocyte Common AntigensPlatelet Glycoprotein GPIIb-IIIa ComplexPTPRC protein, humanleukocytesnext-generation RNA-seqplateletsplatelet transcriptomics

Identifiers

PMID38969303
PMCPMC11416310

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.